Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Balsams”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 recordsLinked to original sources
PubMed1985

Reduction of intake of balsams in patients sensitive to balsam of Peru.

64 patients participated in this study. 24 were patients who had positive patch tests to balsam of Peru. The dermatitis of 9 of the patients had flared after open oral challenge with balsam of Peru, and the dermatitis of 31 patients had flared after double-blind oral challenge. All 64 patients were asked to avoid food items suspected of containing balsams for 1 to 2 months. At the end of that time, an evaluation of the diet trial was made; the dermatitis of 37 had cleared or improved markedly. If an improvement had taken place, the patient was asked to continue to diet moderately. 6 months to 3 years after the diet was initiated, a questionnaire was mailed to those patients whose dermatitis had improved after the first trial. The patients were asked to evaluate the long-term benefit of following the diet. 30 felt there was a long-term effect, and 27 still followed the diet instructions to some degree.

Balsams↗
PubMed1985

Oral challenge with balsam of Peru.

A placebo-controlled, double-blind, oral challenge with balsam of Peru was carried out in 221 patients with various types of dermatitis. 210 patients completed the study, and 45 of them experienced a flare of their symptoms after challenge with balsam of Peru but not after placebo. 15 patients reacted to the placebo, and 5 reacted to both balsam and placebo. Specific reactivity to balsam of Peru was seen particularly in patients with positive patch tests to this compound and in some patch-test-negative patients with vesicular hand eczema, ano-genital and axillary eczema. Dietary restriction of the intake of balsams was followed by marked improvement or clearance of the dermatitis in approximately half of the patients who adhered to the diet for at least 1 month.

Administration, Oral↗
PubMed1977

Balsam of Peru as screening agent for essential oils sensitivity.

The standard series and 35 essential oils were tested on 450 patients with dermatitis. It was found that those simultaneously sensitive to essential oils are more frequently negative than positive to balsam of Peru. The remaining 3 balsams, however (colophony, turpentine and wood tars), are also screening agents for essential oils. All four balsams reveal sensitivity to essential oils in most of the subjects tested. In patients negative to all 4 balsams of the standard series, attempts to find an essential oil with which tests would be simultaneously frequently positive with those for other essential oils failed.

Balsams↗
PubMed1990

Perfume dermatitis in children sensitized to balsam of Peru in topical agents.

Hjorth in his classic monogram "Eczematous Allergy to Balsams" emphasized that sensitization to balsam of Peru is most important since secondary allergens such as "fragrances" are ubiquitous. The application of a topical medication containing balsam of Peru to the skin of an infant, particularly in the occluded diaper area, seems a great way to sensitize the infant not only to balsam of Peru but also to our fragrant environment.

Administration, Topical↗
PubMed1977

Immediate reactions to patch tests with balsam of Peru.

Closed patch tests with balsam of Peru gave rise to nine immediate reactions among 121 patients with different dermatoses and to 10 reactions among 57 patients with chronic urticaria. Among compounds of balsam of Peru, cinnamic aldehyde, cinnamic acid benzoic acid and benzaldehyde also gave the same reactions. The reactions could not passively be transferred with serum from patients. They were abolished by antihistamine given before testing, and by pretreatment with compound 48/80. Balsam of Peru and cinnamic aldehyde did not provoke new symptoms when given orally to patients.

Balsams↗
PubMed1992

Propolis allergy (IV). Studies with further sensitizers from propolis and constituents common to propolis, poplar buds and balsam of Peru.

26 different compounds have been investigated experimentally for their sensitizing capacity in guinea pigs. 19 of these occur in propolis as well as in poplar bud exudates, and 14 of them are also found in balsam of Peru. 4 caffeates and benzyl isoferulate were found to be strong sensitizers. 7 compounds were moderate, and 13 compounds showed only weak sensitizing potency. Methyl cinnamate was negative. Patch tests in 11 propolis-sensitive patients once more revealed 3-methyl-2-butenyl caffeate and phenylethyl caffeate as the major sensitizers. In addition to the 8 compounds already known to occur in propolis as well as in balsam of Peru, we detected 5 further substances that both materials have in common. Among these, benzyl isoferulate is considered a noteworthy sensitizer. Coniferyl benzoate, which was shown to be a moderate sensitizer, is present in fresh samples of balsam of Peru, while in propolis it has been detected only once so far. The flavonoid aglycones occurring in poplar bud exudates, and hence also in propolis, are weak sensitizers which play only a minor role in propolis hypersensitivity.

Allergens↗
PubMed1992

[Inhibitory effects of balsam pear on the mutagenic activity of cyclophosphamide in vivo].

Inhibitory effects of balsam pear on the mutagenic activity of cyclophosphamide were studied in the cells of bone marrow of mouse in vivo. It was found that balsam pear juice itself showed no effect on the incidence of sister chromatid exchanges (SCE) and of micronuclei (MN) on the cells of bone marrow. But balsam pear juice reduced the incidence of SCE (from 29.1 times/cell to 13.27-28.38 times/cell) and MN (from 60.0% to 27.0%-50.0%) induced by cyclophosphamide respectively. The inhibitory effects showed a dose-dependent relation, which was statistically significant.

Animals↗
PubMed1979

[Immunohistochemical identification of specific antigens in stained and balsam-embedded eye lens sections].

Localization of specific proteins at preliminary stained with azan and embedded in balsam sections of amphibian eye lens (Rana temporaria, Xenopus laevis) was studied by indirect immunofluorescence. The analysis was performed on the lens of intact animals as well as on lens induced in amphibia gastrula ectoderm in vitro. To remove balsam the lens sections were successively washed by xylene, ethanol and saline (pH 7.1). Then they were treated according to the general principles of immunohistochemical analysis. Specific antigens have been thus shown to be detectable at lens sections which had been kept in balsam for over a year. The immunofluorescent reaction to lens proteins was negative at more prolonged storage of the sections (2--3 years).

Animals↗
PubMed1983

Standard photopatch testing with Waxtar, para-aminobenzoic acid, potassium dichromate and balsam of Peru.

194 patients were standard photopatch tested with Waxtar as is (coal tar 5%) and 161 patients were photopatch tested with para-aminobenzoic acid (PABA) 5% in alcohol, potassium dichromate 0.5% in petrolatum, and a mixture of balsams of Peru as is. The photopatches were irradiated with UVA. 40 patients (25%) had phototoxic reactions to Waxtar and 4 of them showed pigmentation after 7 days. Only a few patients had photocontact urticaria. 1 patient had a late-reaction to PABA and showed a cross-reaction to glyceryl PABA but a negative reaction to paraphenylenediamine (PPD) and benzocaine 5% in the standard test. No patients had positive photopatch reactions to potassium dichromate when irradiated with UVA. 2 patients had phototoxic reactions to balsam of Peru. None had photoallergic reactions. Standard photopatch testing is a time consuming procedure which creates problems both for the staff and for the patients. The yield of unexpected, relevant positive reactions is insignificant. From a cost-benefit view, photopatch testing is only warranted in cases giving rise to a clinical suspicion of photodermatitis.

4-Aminobenzoic Acid↗
PubMed1978

Inhibition of growth and guanylate cyclase activity of an undifferentiated prostate adenocarcinoma by an extract of the balsam pear (Momordica charantia abbreviata).

We have recently described the presence of a guanylate cyclase [GTP pyrophosphate-lyase (cyclizing), EC 4.6.1.2] inhibitor (GCI) in an aqueous extract of the balsam pear (Momordica charantia abbreviata). Because the guanylate cyclase-cyclic GMP system is though to be involved in cell growth, DNA and RNA synthesis, and possible malignant transformation, we examined the effect of the aqueous extract containing GCI on an undifferentiated adenocarcinoma of the rat prostate and concanavalin-A-stimulated [3H]thymidine incorporation into cultured splenic lymphocytes, a process thought to be mediated by cyclic GMP. The results demonstrate that the extract of the balsam pear blocks both the growth of the rat prostatic adencarcinoma in vitro and [3H]thymidine incorporation into DNA. DNA histograms from flow cytometry indicated that the extract containing GCI inhibited in the G2 + M phase of the cell cycle, a presumed locus of cyclic GMP effects. In addition, guanylate cyclase activity was significantly greater in the tumor than normal prostate tissue and was decreased by the extract containing GCI. Cyclic GMP levels in the tumor in culture wer also decreased by addition of the extract. It remains to be determined whether or not the anti-tumor agent and GCI are the same substance.

Adenocarcinoma↗
PubMed1981

[Guacetisal: a new molecule with balsamic-antiphlogistic action. Clinical study].

An open clinical trial was run on the therapeutic efficacy of a new balsamic-antiinflammatory molecule, guacetisal (presented as 500 mg Broncaspin capsules). The drug was given for a minimum of 7 days to 45 male and female patients with an average age of 64 yr suffering from variously serious diseases of the airways. The concomitant administration of fluidifying, balsamic, steroid, antipyretic and anti-inflammatory drugs was avoided, whereas various combinations of cardiokinetics, diuretics, theophyllines, and antibiotics were used where required. Clinical assessment of the parameters chosen pointed to the good therapeutic activity of the preparation, which is specifically indicated in inflammatory conditions of the airways, especially chronic forms subject to periodic recrudescence. Its equally good tolerability serves to make guacetisal extremely easy to use, with the results that its employment in non-specialist environments can also be recommended.

Adult↗
PubMed1989

Use of a trypsin, Peru balsam, and castor oil spray on the oral mucosa: case report and review of the literature.

Granulex is an aerosolized spray (Dow B. Hickman Pharmaceuticals, Sugar Land, TX 77487) that contains trypsin, Peru balsam, and castor oil. It has been available for many years as a topical spray for the treatment of decubitus ulcers. We used Granulex to promote tissue healing of a necrotic ulcer of the oral mucosa in a patient with advanced oropharyngeal squamous cell carcinoma.

Adult↗
PubMed1984

Purpuric vasculitis-like eruption in a patient sensitive to balsam of Peru.

A case is reported of secondary dissemination of allergic contact dermatitis in a patient sensitive to balsam of Peru. The primary eruption was located in the face. The secondary lesions appeared as purpuric vasculitis-like eruptions on both legs. Such an unusual manifestation of contact dermatitis may cause considerable delay in establishing the correct diagnosis.

Aged↗
PubMed1989

Effects of two gutta-percha formulations and one zinc oxide-eugenol and Canada balsam mixture on human blood monocytes and lymphocytes.

In this study we performed an in vitro assay of the effects of two gutta-percha formulations and one zinc oxide-eugenol and Canada balsam-based endodontic material on the behavior of a mixed cell population of human monocytes and lymphocytes. Cells were cultured either in direct contact with or near experimental samples of Ultrafil, standard gutta-percha cones or Endoseal and the inhibitory effects of these materials upon cell attachment and spreading on test surfaces were analyzed. Ultrafil and the standard gutta-percha cones showed little or no adverse effects, whereas the inhibitory effects of Endoseal appeared to be severe. There were statistically significant differences between the results obtained from both Ultrafil and gutta-percha cones and those obtained from Endoseal. Differences between all tested materials and their respective controls were also statistically significant.

Balsams↗
PubMed1978

[Contact urticaria caused by Peru balsam].

By tests on six patients with recurrent urticaria it could be demonstrated that it was caused by an allergy against Peru balsam. Different reaction types seem to have been responsible for the occurrence of the urticaria. Cross reactions with different other substances, mainly luxury food and stimulants, play a particular part.

Adult↗